Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.

• 1. Biology of the iron efflux transporter, ferroportinGautam Rishi and V. Nathan Subramaniam2. The effect of sport and physical activity on transport proteins: implications for cancer prevention and controlMaha Sellami and Nicola Luigi Bragazzi3. Cancer bioenergetics as emerging holistic cancer theory: the role of metabolic fluxes and transport proteins involved in metabolic pathways in the pathogenesis of malignancies. State-of-the-art and future prospects Nicola Luigi Bragazzi and Maha Sellami4. Investigating mutations at the hotspot position of the ERBB2 and screening for the novel lead compound to treat breast cancer – a computational approachD. Thirumal Kumar, S. Udhaya Kumar, R. Magesh and C. George Priya Doss5. Autophagy proteins and its homeostasis in cellular environmentVrushali Guhe, Bhavnita Soni, Prajakta Ingale and Shailza Singh6. Expression of placental glucose transporter proteins in pregnancies complicated by fetal growth disordersPawel Jan Stanirowski, Michal Lipa, Dorota Bomba-Opo and Miroslaw Wielgos7. The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseasesCamila Campos-Escamilla8. ABCG: a new fold of ABC exporters and a whole new bag of riddles!Atanu Banerjee, Alexis Moreno, Jorgaq Pata, Pierre Falson and Rajendra Prasad9. Serum albumin: clinical significance of drug binding and development as drug delivery vehicleSaad Tayyab and Shevin Rizal Feroz10. PTR2/POT/NPF transporters: what makes them tick?Bala K. Prabhala, Moazur Rahman, Hussam H. Nour-eldin and Flemming Steen Jørgensen and Osman Mirza11. Network analysis of transcriptomics data for the prediction and prioritization of membrane-associated biomarkers for idiopathic pulmonary fibrosis (IPF) by bioinformatics approachSmriti Mishra, Mohammad Imran Shah, S. Udhaya Kumar, D. Thirumal Kumar, Chandrasekhar Gopalakrishnan, Abeer Mohammed Al-Subaie, R. Magesh, C. George Priya Doss and Balu Kamaraj